Neggoz, I don’t think there is a silver bullet here, but look at the pipeline and the Aussie results ... Dermatitis is our biggest and most thoroughly evaluated .. that’s what the Anacor transaction was based on, stick around!!
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-140
-
- There are more pages in this discussion • 511 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 38.0¢ | $479.7K | 1.251M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 207968 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 717885 | 12 |
View Market Depth
| Last trade - 10.15am 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |